Why Bayer (BAYRY) Stock Is Surging Today

NEW YORK (TheStreet) -- Bayer (BAYRY) plans to list its less profitable plastics business on the stock market in a deal that could value the division at about $13 billion as it focuses on healthcare, veterinary drugs and crop protection, Reuters reports.

The planned spin-off of the Material Science division, where profit margins are less than half the company average, follows a wider healthcare industry trend of divesting weaker businesses and bulking up in areas of strength, Reuters said.

Shaares of Bayer are up 4.56% to $143.43 in pre-market trade today.

BAYRY Chart BAYRY data by YCharts

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE.

If you liked this article you might like

European Pharma Companies Slip on MS Pricing Probe

Bayer Offers Concessions in $66 Billion Monsanto Deal to Ease Competition Concerns

European Benchmarks Slump After Earnings Calamity - FDA Socks London